IGHS celebrates the inauguration of new Insparya Clinic at Oman International Hospital

With the presence of the distinguished shareholders, Sheika Amal Suhail Bahwan - representing Suhail Bahwan Group, and Mr. Fathi Al Balushi - representing Oman Brunei Investment Company, Insparya announces its strategic partnership with IGHS, inaugurating its new branch at Oman International Hospital.

This landmark alliance not only symbolised a union of expertise and vision but also promises to redefine the landscape of aesthetic healthcare in the region.

At the heart of this collaboration lies a shared commitment to excellence, innovation, and the delivery of exceptional patient care. IGHS, with its esteemed reputation as a leading healthcare institution in Oman, brings to the table a wealth of experience and resources, coupled with an unwavering dedication to advancing medical excellence across multiple specialties.

Through this collaboration, patients of Insparya Clinic can benefit from an integrated care, with access to a wide range of medical services and specialties offered by Oman International Hospital. From pre-operative consultations to post-operative care, the synergy between Insparya Clinic and IGHS promises a seamless and personalised experience for every individual seeking aesthetic enhancement and wellness.

As the doors of Insparya Clinic in Oman open to welcome patients looking for transformative beauty and confidence, the partnership with IGHS and OIH stands as a cornerstone of excellence and synergy. 

Together, we embark on a shared journey of empowerment, innovation, and integrated healthcare, ready to make a long lasting impact on the lives of millions of people living in the Sultanate of Oman and the GCC region.

• Innov.Cell ended its successful participation in CPHI 2024

  Innov.Cell, a subsidiary of IGHS, ended its successful participation in CPHI 2024, which took place in Milan, with a positive outcome. This year, CPHI was attended by more than 62,000 people and around 2,400 exhibitors from 166 countries. Throughout the event, Innov.Cell met with several potential partners, from R&D, investors, and distributors covering more than 50 countries.

  Read more
• OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)

  Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
   

  Read more